Device Saves Lives in Heart Failure Patients

Heart within a man's body.In 2009, Rochester researchers reported in the New England Journal of Medicine that cardiac resynchronization therapy with defibrillator (CRT-D therapy) reduced heart failure in patients with mild forms of the disease. The trial, known as MADIT-CRT, led the FDA in 2010 to extend the approval of CRT-D therapy to patients with mild heart failure and left bundle branch block, a condition that results in disorganized electrical activity throughout the heart. The device was originally approved to treat patients with severe heart failure.

The researchers, led by Arthur J. Moss, M.D., professor of Cardiology, are back in the New England Journal of Medicine this week with the results of the MADIT-CRT long-term follow-up study. Also presented at the American College of Cardiology’s 63rd Annual Scientific Session, the study shows for the first time that CRT-D therapy saves the lives of mild heart failure patients over the long term.

Read more about the study here

Emily Boynton | 3/31/2014 | 0 comments


Blog post currently doesn't have any comments.
Leave a comment

 Security code

About the Blog

The goal of this blog is to bring more medical research stories to light and provide our readers with timely and engaging coverage of scientific and medical developments here in Rochester and beyond.

Follow @URMCResearch

Though health advice offered here is provided by experts, there is no substitute for the personal care your own provider can offer. If you have medical questions or concerns, please contact your physician.

Blog posts